Log in to post a reply
Aug 15, 2013 04:41PM
Aug 15, 2013 04:54PM
Flannelette, I have so many post because I am addicted to the games!! I didn't start posting until I was done with treatment (except Arimidex) either. I found I was gravitating to the 'I am having a terrible time with......" (Fill in the blank) and didn't need that. I had done my research, knew what I needed to do, so just did it. Why I spent here now is: I have made some great friends whom I really like to hang out with, I like to do research & am a teacher, so am happy if some of the things I've learned can help others, and when I was first diagnosed, what helped me most was to talk to other people who had 'been there/done that'. Who 'got' what I was going through, and who had come out of it really OK. So hopefully I can be an encouragement for a few people that way too. Plus the exercise and weigh in threads keep me accountable!
OK, back to my 'teacher mode' . Here is something about aspirin (which I was already taking for heart health) taken from an article dated 4/23/2013. (Of course, clear it with you doctor if you think you want to start this.)
New Evidence That Aspirin May Prevent Cancer
Taking a low dose of aspirin every day could have the potential to prevent breast cancer or stop it in its tracks.
That was the news over the weekend from the annual meeting of the American Society for Biochemistry and Molecular Biology in Boston, where a team of researchers from the Veterans Affairs Medical Center in Kansas City and the University of Kansas Medical Center presented evidence demonstrating the effects of aspirin against two types of breast cancer.
One of them, so-called “triple negative” cancer, is the most aggressive type of breast cancer and also the most dangerous because it often doesn’t respond to conventional therapies.
Last year, another study also conducted at the University of Dundee in Scotland found similar results in 116, 181 women who take aspirin regularly. A 30-percent lower risk of breast cancer was found in women who took aspirin for three to five years and a 40 percent risk reduction was found after more than five years of aspirin use.
Breast cancer is just one of many types of cancer that are being studied in relation to the lowly painkiller. Previous research has shown the potential of low-dose aspirin to:
The most exciting research on the aspirin-cancer connection came last year, when three related studies were published simultaneously in The Lancet and The Lancet Oncology. The first of the studies looked at aspirin and the likelihood of dying from cancer. Analyzing the data from 51 randomized trials, the authors found that aspirin reduced death from cancer by 15 percent and that the benefit increased over time, rising to 37 percent after five years.
The second study looked at the effect of aspirin on cancer metastases and found that aspirin appeared to reduce the risk of cancer spreading by 36 percent over 6.5 years. A third study was an analysis of data from a number of studies that followed people over time, and the results of this study appeared to confirm the other two.
At the time, Peter Rothwell of Oxford University, the lead researcher on the studies and one of the world’s leading experts on aspirin and cancer, summed up his conclusions by saying: ”Aspirin reduces the likelihood that cancers will spread to distant organs by about 40-50 percent.”
How Does It Work (If It Works)?
There are two explanations offered for aspirin’s possible cancer-protective effects. One is that its anti-inflammatory action prevents the inflammation that’s thought to trigger or boost the growth of cancerous cells.
But some studies, including yesterday’s breast cancer news, suggest that aspirin’s target is cancer stem cells, the stubborn cells at the root of tumor growth and metastasis.
The lead researcher for the new breast cancer studies, Sushanta Banerjee, director of the cancer research unit at the University of Kansas, noted that chemotherapy for breast cancer does not necessarily kill stem cells, which will restart tumor growth if they survive.
The research so far suggests that aspirin is more effective against one type of cancer, adenocarcinomas, than against other types. Most colorectal, esophageal, prostate and breast, and some lung cancers are adenocarcinomas.
Aspirin-Cancer Connection Research Still In Early Stage, Experts Caution
Like most of the aspirin and cancer studies to date, yesterday’s breast cancer research was of the preliminary type, in this case a test tube study using cancer cell lines and further testing in mice. However, it’s exciting in the way that it extends the knowledge gained from previous aspirin and cancer studies.
"Invisible threads are the strongest ties." Friedrich Nietzsche
2/2007, Stage IIA, Grade 3, 0/11 nodes, ER+/PR-, HER2-